The effect of trimetazidine in heart failure on clinical endpoints: a systematic review

Back

HFA Premium Access

The effect of trimetazidine in heart failure on clinical endpoints: a systematic review

Session: Chronic heart failure - pathophysiology and mechanisms 13

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Mr S. Nassiri (Amsterdam, NL)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Mr Soufiane Nassiri

VU University Medical Centre, Amsterdam (Netherlands (The))

0 follower

6 more presentations in this session

Development of an Advanced Nurse Practitioner Led clinic to enhance access to heart failure diagnosis and treatment

Speaker: Ms N. Caples (Waterford, IE)

Acceptance, use and effect of a mobile application for heart failure patients. A pilot study

Speaker: Associate Professor F. Schoenrath (Berlin, DE)

How can we increase adherence to medical treatment in heart failure patients? A questionnaire study

Speaker: Assistant Professor A. Sahin (Sivas, TR)

Characterization of dilated cardiomyopathy patients with persistently reduced ejection fraction

Speaker: Doctor I. Campos (Penafiel, PT)

Impact of optimal guideline-directed medical therapy on morbidity and mortality in patients with severely reduced ejection fraction from chronic aortic regurgitation undergoing aortic valve surgery

Speaker: Doctor A. Cinq-Mars (Paris, FR)

Access the full session

Chronic heart failure - pathophysiology and mechanisms 13

Speakers: Mr S. Nassiri, Ms N. Caples, Associate Professor F. Schoenrath, Assistant Professor A. Sahin, Doctor I. Campos...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources